APA (7th ed.) Citation

Zhou, J., Zhu, Y., Ai, D., Zhou, M., Li, H., Li, G., . . . Song, J. (2023). Advanced glycation end products impair bone marrow mesenchymal stem cells osteogenesis in periodontitis with diabetes via FTO-mediated N6-methyladenosine modification of sclerostin. Journal of Translational Medicine, 21(1), 1. https://doi.org/10.1186/s12967-023-04630-5

Chicago Style (17th ed.) Citation

Zhou, Jie, Yanlin Zhu, Dongqing Ai, Mengjiao Zhou, Han Li, Guangyue Li, Leilei Zheng, and Jinlin Song. "Advanced Glycation End Products Impair Bone Marrow Mesenchymal Stem Cells Osteogenesis in Periodontitis with Diabetes via FTO-mediated N6-methyladenosine Modification of Sclerostin." Journal of Translational Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12967-023-04630-5.

MLA (9th ed.) Citation

Zhou, Jie, et al. "Advanced Glycation End Products Impair Bone Marrow Mesenchymal Stem Cells Osteogenesis in Periodontitis with Diabetes via FTO-mediated N6-methyladenosine Modification of Sclerostin." Journal of Translational Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12967-023-04630-5.